ADHD Assessment Pathway
Step 3 of 3
GP prescribing and ongoing management
If ADHD is diagnosed by the psychiatrist, a detailed report will be sent to Dr Shaw outlining recommended treatment options. This step covers commencing medication and your long-term monitoring plan.
Prescribing approval
~10
Approval timeline
days (occasionally longer)
Vic DoH
Issued by
Victorian Dept of Health
Follow-up consultation
Psychiatrist's recommendations will be reviewed
Medication options will be discussed in detail
A personalised treatment plan will be developed
Referrals issued for repeat investigations (blood tests, ECG, urine drug screen) required prior to your 6-month review
Costs and care planning
With CDM plan (chronic disease management)
Consultation fee$220 - $248 (time dependent)
Medicare rebate$156.55
Out-of-pocket gap~$64 - $92
Without CDM plan
Consultation fee$193.90
Medicare rebate$43.90
Out-of-pocket gap$150
Fees are indicative and may vary slightly.
Medication options
First-line · Stimulant
Dexamfetamine
Also known as lisdexamfetamine
Methylphenidate
Also known as Ritalin, Concerta
Non-stimulant options
Atomoxetine
Alternative where stimulants unsuitable
Guanfacine
May assist with sleep-related side effects
Clonidine
Used in combination or standalone
Starting treatment
Authority to prescribe obtained
Prescribing authority is arranged during the follow-up consultation.
Start at a low dose
Treatment begins conservatively to minimise side effects and assess response.
Gradual dose titration
Dose is adjusted gradually — usually weekly. Follow-up during this phase is often brief and may be by phone.
Effective dose established
Prescriptions are then provided for up to 6 months at a time.
Ongoing monitoring
6-month review (face-to-face required)
Blood pressure and pulse checked
Repeat ECG and blood tests reviewed
If stable, further routine testing is generally not required until the end of the 2-year permit period
Urine drug screening may be required at any time if clinically indicated
Pathway complete
Following stabilisation of treatment, ongoing management continues through regular GP follow-up as needed. Dr Shaw will be your primary point of contact for prescribing, monitoring, and any concerns.